Focus: Salix Pharmaceuticals is a specialty pharmaceutical company focused on small-molecule treatments for gastroenterology and neurology, headquartered in Bridgewater, NJ. The company generates 83% of revenue from its flagship product TRULANCE, indicating a highly concentrated portfolio dependent on a single asset.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Salix Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Salix Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Salix Pharmaceuticals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Flagship revenue driver (83% of company revenue) with guanylate cyclase activator mechanism and 10+ years of patent protection.
Peripherally-acting mu-opioid antagonist addressing growing OIC indication with patent protection through 2031.
Anti-inflammatory 5-ASA therapy for IBD with approaching LOE in 2030 and modest revenue contribution.
Corticosteroid formulation for UC with patent protection through 2031 targeting inflammatory bowel disease.
Laxative bowel prep agent with extended patent life until 2033, generating modest but stable revenue.
3 discontinued, 1 duplicate formulations not shown
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo